Matthew S. Lawrence

4.5k total citations · 1 hit paper
53 papers, 3.6k citations indexed

About

Matthew S. Lawrence is a scholar working on Molecular Biology, Ophthalmology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Matthew S. Lawrence has authored 53 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 17 papers in Ophthalmology and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Matthew S. Lawrence's work include Glaucoma and retinal disorders (10 papers), Retinal Diseases and Treatments (9 papers) and Herpesvirus Infections and Treatments (7 papers). Matthew S. Lawrence is often cited by papers focused on Glaucoma and retinal disorders (10 papers), Retinal Diseases and Treatments (9 papers) and Herpesvirus Infections and Treatments (7 papers). Matthew S. Lawrence collaborates with scholars based in United States, Germany and Ireland. Matthew S. Lawrence's co-authors include Susanna Obad, Sakari Kauppinen, Marie Lindholm, Andreas Petri, Henrik F. Hansen, Ellen Marie Straarup, Maj Hedtjärn, Sylvia Schütz, Peter Sarnow and Urs V. Berger and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Comparative Neurology.

In The Last Decade

Matthew S. Lawrence

52 papers receiving 3.5k citations

Hit Papers

LNA-mediated microRNA silencing in non-human primates 2008 2026 2014 2020 2008 400 800 1.2k

Peers

Matthew S. Lawrence
Dietrich Stephan United States
Nicole A. Datson Netherlands
Yvan Arsenijévic Switzerland
Ann Acheson United States
Matthew S. Lawrence
Citations per year, relative to Matthew S. Lawrence Matthew S. Lawrence (= 1×) peers Philip A. Barker

Countries citing papers authored by Matthew S. Lawrence

Since Specialization
Citations

This map shows the geographic impact of Matthew S. Lawrence's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew S. Lawrence with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew S. Lawrence more than expected).

Fields of papers citing papers by Matthew S. Lawrence

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew S. Lawrence. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew S. Lawrence. The network helps show where Matthew S. Lawrence may publish in the future.

Co-authorship network of co-authors of Matthew S. Lawrence

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew S. Lawrence. A scholar is included among the top collaborators of Matthew S. Lawrence based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew S. Lawrence. Matthew S. Lawrence is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lawrence, Matthew S., et al.. (2023). Tolerability and tropism of recombinant adeno-associated virus vectors in the African green monkey (Chlorocebus sabaeus) anterior chamber. Gene Therapy. 30(9). 714–722. 1 indexed citations
2.
Illanes, Oscar, et al.. (2023). Naturally occurring histological findings and Alzheimer's‐like pathology in the brain of aging African green monkeys ( Chlorocebus sabaeus ). The Journal of Comparative Neurology. 531(13). 1276–1298. 3 indexed citations
3.
Rotenstreich, Ygal, et al.. (2023). A Novel Device for Suprachoroidal Drug Delivery to Retina: Evaluation in Nonhuman Primates. Translational Vision Science & Technology. 12(6). 3–3. 2 indexed citations
4.
Patel, Chintan, Robin J Goody, Wenzheng Hu, et al.. (2020). Primate model of chronic retinal neovascularization and vascular leakage. Experimental Eye Research. 195. 108031–108031. 8 indexed citations
5.
Hudson, Natalie, A. Hopkins, Chris Greene, et al.. (2019). Dysregulated claudin-5 cycling in the inner retina causes retinal pigment epithelial cell atrophy. JCI Insight. 4(15). 50 indexed citations
6.
Hu, Wenzheng, et al.. (2017). Quantification of aflibercept and ranibizumab efficacy in DL-2-aminoadipic acid (DLAAA)-induced retinal neovascularization and vascular leakage in nonhuman primates. Investigative Ophthalmology & Visual Science. 58(8). 210–210. 2 indexed citations
7.
Halley, Paul, Beena M. Kadakkuzha, Mohammad Ali Faghihi, et al.. (2014). Regulation of the Apolipoprotein Gene Cluster by a Long Noncoding RNA. Cell Reports. 6(1). 222–230. 177 indexed citations
8.
Goody, Robin J, et al.. (2013). Definition of Normal Ophthalmic Measures in the African Green Monkey. Investigative Ophthalmology & Visual Science. 54(15). 1988–1988. 1 indexed citations
9.
Ward, Keith W., et al.. (2012). The Use of the African Green Monkey as a Preclinical Model for Ocular Pharmacokinetic Studies. Journal of Ocular Pharmacology and Therapeutics. 28(3). 290–298. 9 indexed citations
11.
Lawrence, Matthew S. & Joan W. Miller. (2004). Ocular Tissue Permeabilities. International Ophthalmology Clinics. 44(3). 53–61. 17 indexed citations
12.
Lawrence, Matthew S.. (2003). Effects of Bending, Lifting and Valsalva Maneuver on Intraocular Pressure. Investigative Ophthalmology & Visual Science. 44(13). 1297–1297. 1 indexed citations
13.
Zhao, Heng, Midori A. Yenari, Matthew S. Lawrence, et al.. (2001). Bcl-2 Overexpression Protects Against Neuron Loss in Peri-infarct Regions Following Experimental Stroke. Stroke. 32. 326–327. 1 indexed citations
14.
Dumas, Theodore C., Esther M. John, Dora Y. Ho, Matthew S. Lawrence, & Robert M. Sapolsky. (2000). Gene Therapies That Enhance Hippocampal Neuron Survival after an Excitotoxic Insult Are Not Equivalent in Their Ability to Maintain Synaptic Transmission. Experimental Neurology. 166(1). 180–189. 28 indexed citations
15.
Phillips, Russell G., Matthew S. Lawrence, Dora Y. Ho, & Robert M. Sapolsky. (2000). Limitations in the neuroprotective potential of gene therapy with Bcl-2. Brain Research. 859(2). 202–206. 26 indexed citations
16.
Taylor, Jane R., John D. Elsworth, Matthew S. Lawrence, et al.. (1999). Spontaneous Blink Rates Correlate with Dopamine Levels in the Caudate Nucleus of MPTP-Treated Monkeys. Experimental Neurology. 158(1). 214–220. 154 indexed citations
17.
Lawrence, Matthew S., Dora Y. Ho, Laura J. McIntosh, et al.. (1997). Herpes Simplex Viral Vectors Expressing Bcl-2 Are Neuroprotective When Delivered After a Stroke. Journal of Cerebral Blood Flow & Metabolism. 17(7). 740–744. 123 indexed citations
18.
Dash, Rajesh, Matthew S. Lawrence, Dora Y. Ho, & Robert M. Sapolsky. (1996). A Herpes Simplex Virus Vector Overexpressing the Glucose Transporter Gene Protects the Rat Dentate Gyrus from an Antimetabolite Toxin. Experimental Neurology. 137(1). 43–48. 29 indexed citations
19.
Lawrence, Matthew S. & Robert M. Sapolsky. (1994). Glucocorticoids accelerate ATP loss following metabolic insults in cultured hippocampal neurons. Brain Research. 646(2). 303–306. 93 indexed citations
20.
Lawrence, Matthew S. & D. Eugene Redmond. (1991). MPTP lesions and dopaminergic drugs alter eye blink rate in African green monkeys. Pharmacology Biochemistry and Behavior. 38(4). 869–874. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026